Pernod Ricard SA (EPA: RI) reports organic net revenue decline year-on-year in Q1 FY2027 sales update (July–September 2026, publication approx. October 2026, confirmed by Pernod Ricard Investor Relations or Bloomberg by October 31, 2026)
Pending
✦ AI-generated prediction
Published on 18. September 2026
·
Predicted for 23. October 2026
·
Based on: Historical Cycle
The international spirits industry is experiencing pronounced demand weakness: Brown-Forman reported a −1% organic net revenue decline for Q1 FY2027 (May–July 2026) — an already widespread trend. Diageo (open Cassandra forecast: H1 FY2026/27 decline), AB InBev, and Heineken show similar structural weaknesses. Pernod Ricard's key brands Jameson, Chivas Regal, and Martell are suffering from US destocking and China demand weakness — both effects already manifested in negative organic rates in FY2024/25 and FY2025/26. The Q1 FY2027 sales update is typically published mid-to-late October (historical anchor: Q1 FY2024/25 on October 17, 2024). No Polymarket market available; industry trend estimate: 68%.
Data basis for this prediction
- Brown-Forman Q1 FY2027 (Mai–Juli 2026): organisches Nettoumsatzminus −1 % (SEC 8-K / Alphastreet, 2. September 2026)
- Pernod Ricard FY2025/26: organisches Wachstum negativ (Pernod Ricard Investor Relations / Bloomberg, 2026)
- Pernod Ricard Q1-Update historischer Zeitplan: Q1 FY2024/25 am 17. Oktober 2024 (IR-Kalender)
- IWSR / Euromonitor: globale Destocking-Phase Spirituosen USA + China dauert an (2026)
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
🍾 Beverages
✦ AI
The global premium spirits market is in a sustained sales crisis: Diageo itself reported an organic net revenue decline of −2.0% for FY2025/26 (July 2025–June 2026) (volume −0.4%, price/mix effect −1.6%, Diageo Preliminary Results, July 2026). Peer Brown-Forman also recorded −1% organic in Q1 FY2027 (May–July 2026) (confirmed Cassandra hit, September 2, 2026). Pernod Ricard is also expected to show an organic decline in Q1 FY2026/27 per an open prediction. Common drivers: consumer restraint in the US (high rates at 3.75–4.00% after Fed hike), China slowdown in baijiu/whisky segment, premiumization backlash, and buyer substitution toward RTD products. The base effect (−2% in FY2026) could make H1 FY2026/27 mathematically easier to beat, but deteriorating conditions in the second half of 2026 still argue for continued negative organics.
🍾 Beverages
✦ AI
Rémy Cointreau returned to positive territory in full-year FY2025/26 with +0.2% organic revenue growth — after a disastrous -18.0% in FY2024/25. Crucially, the H1 FY2025/26 comparison period (April–September 2025) was still weak at -4.2% organic. This low base materially eases the path to positive organic growth in H1 FY2026/27. Supportive: US cognac destocking cycle largely complete, recovering premium spirits demand in select markets. Risks: China VIP demand remains subdued, APAC recovery slow. Countervailing signals: Pernod Ricard and LVMH Wines & Spirits are still forecast to decline organically on this platform. No Polymarket market available; self-assessed probability 60%.
🍾 Beverages
✦ AI
Constellation Brands (Corona, Modelo, Pacifico, Kim Crawford) posts its seasonally strongest quarter (June–August, US beer season), typically ~28–32% above annual average. FY2025 full-year revenue was ~$10.2B (~$2.55B quarterly average). Q2 FY2026 (June–August 2025) estimated at ~$2.85–2.95B by analysts. With continued beer segment growth of +3–6% YoY (premiumization, Hispanic demographics) and stable pricing, Q2 FY2027 is expected to exceed $2.95B. Wine/spirits segment remains under pressure but has reduced weight. No specific prediction market data available.